Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer.
| Autor: | Masami Morimoto, Hiroaki Toba, Mariko Aoyama, Misako Nakagawa, Hirokazu Takechi, Takahiro Yoshida, Akira Tangokul, Morimoto, Masami, Toba, Hiroaki, Aoyama, Mariko, Nakagawa, Misako, Takechi, Hirokazu, Yoshida, Takahiro, Tangoku, Akira |
|---|---|
| Zdroj: | Clinical Breast Cancer; Dec2020, Vol. 20 Issue 6, p448-453, 6p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
Full Text from ScienceDirect